These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1386810)

  • 1. The acute thrombogenicity of an infection-resistant rifampicin-soaked Dacron graft: an experimental study in sheep.
    Lundell A; Bergqvist D; Lindblad B; Leide S
    Eur J Vasc Surg; 1992 Jul; 6(4):403-7. PubMed ID: 1386810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen and gelatin-impregnated vascular grafts--is their thrombogenicity enhanced? An experimental study.
    Jensen N; Lindblad B; Dougan P; Bergqvist D
    Vasa; 1992; 21(4):365-8. PubMed ID: 1485470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
    Sardelic F; Ao PY; Taylor DA; Fletcher JP
    Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a combined thromboxane receptor- and synthesis-antagonist on platelet, fibrinogen and leucocyte uptake in ePTFE grafts: an experimental study in sheep.
    Lundell A; Bergqvist D; Leide S; Lindblad B; Ljungberg J
    Eur J Vasc Surg; 1992 May; 6(3):276-81. PubMed ID: 1534299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin impregnation of a protein-sealed Dacron graft: an infection-resistant prosthetic vascular graft.
    Avramovic JR; Fletcher JP
    Aust N Z J Surg; 1991 Jun; 61(6):436-40. PubMed ID: 1829350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge.
    Vicaretti M; Hawthorne WJ; Ao PY; Fletcher JP
    Cardiovasc Surg; 1998 Jun; 6(3):268-73. PubMed ID: 9705099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of seeded endothelial cells in vivo. A study of Dacron grafts under different flow conditions.
    Jensen N; Linblad B; Leide S; Bergqvist D
    Eur J Vasc Surg; 1994 Nov; 8(6):690-3. PubMed ID: 7828745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombogenicity of gelatine impregnated vascular grafts--an experimental study.
    Pärsson H; Jawien A; Norgren L; Thörne J
    Vasa; 1992; 21(1):6-10. PubMed ID: 1533742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dextran and enoxaparin on early ePTFE graft thrombogenicity in sheep.
    Matthiasson SE; Bergqvist D; Lundell A; Lindblad B
    Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):284-92. PubMed ID: 7542544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep.
    Lundell A; Bergqvist D; Lindblad B
    Eur J Vasc Surg; 1993 Nov; 7(6):698-703. PubMed ID: 8270074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute thrombogenicity of collagen coating of dacron grafts: an experimental study in sheep.
    Konrad P; Dougan P; Bergqvist D
    Eur J Vasc Surg; 1992 Jan; 6(1):67-72. PubMed ID: 1532559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
    Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
    J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of collagen and albumen presealants on knitted Dacron grafts.
    Bearn PE; McCollum CN; Greenhalgh RM
    Eur J Vasc Surg; 1993 May; 7(3):271-6. PubMed ID: 8513906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin.
    Avramovic J; Fletcher JP
    J Cardiovasc Surg (Torino); 1992; 33(1):70-4. PubMed ID: 1531988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a thromboxane receptor antagonist on acute ePTFE arterial graft thrombogenicity--an experimental study in sheep.
    Lundell A; Bergqvist D; Leide S; Lindblad B; Ljungberg J
    Eur J Vasc Surg; 1991 Jun; 5(3):321-6. PubMed ID: 1830856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic potential of synthetic vascular grafts in baboons.
    Schneider PA; Kotzé HF; Heyns AD; Hanson SR
    J Vasc Surg; 1989 Jul; 10(1):75-82. PubMed ID: 2526235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evaluation of small diameter synthetic arterial grafts.
    Pärsson H; Jönsson BA; Norgren L; Strand SE; Thörne J
    Int Angiol; 1988; 7(1):60-4. PubMed ID: 2968426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection. An experimental study.
    Freyrie A; Curti T; Rodio M; Masetti L; Bignozzi L; Sanguinetti V; Joechler M; D'Addato M
    Int Angiol; 1992; 11(2):113-6. PubMed ID: 1402214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.